BIOENGINEER

Ancient Herbal Compounds Show Promise as Light-Activated Weapons Against Drug-Resistant Infections

A new review synthesizes three decades of evidence showing that coumarin, curcumin, riboflavin, pheophorbide a, and hypericin ...
BIOENGINEER

COSMOS Learns Neural Representations as Gauge Dynamics on the Grassmannian

The COSMOS framework trains orthonormal subspace frames with conjugation-based gauge-style updates, holding geometric ...
ainvest

AstraZeneca's bladder-cancer readout is real - it's just confirmation, not a catalyst

AstraZeneca's IMFINZI plus enfortumab vedotin reduced disease progression/recurrence risk by 49% and mortality by 42% in muscle-invasive bladder ...

IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER

Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's IMFINZI® (durvalumab) reduced the risk of death by 58% ...